白癜风诊疗共识（2021版）

doi:10.35541/cjd.20200785

Abstract

Abstract: 【Abstract】 Vitiligo is a common depigmented skin disease， which seriously affects the physical and mental health of patients. According to clinical experience of experts as well as research progress in vitiligo in the past 3 years, the Pigmentary Disorder Group, Combination of Traditional and Western Medicine Dermatology revised the statement "Diagnosis and treatment of vitiligo: an expert consensus statement （2018）" in terms of maintenance treatment of vitiligo and application of glucocorticoids, discussed the prospect for Janus kinase （JAK） inhibitors, and finally established this consensus.

Key words: Vitiligo, Therapy, Glucocorticoids, Phototherapy, Calcineurin inhibitor, Expert consensus

Pigmentary Disorder Group, Combination of Traditional and Western Medicine Dermatology. Consensus on the diagnosis and treatment of vitiligo （2021 version）[J]. Chinese Journal of Dermatology, 2021, 54(2): 105-109.doi:10.35541/cjd.20200785

References ［21］

［1］	中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识（2018版）［J］. 中华皮肤科杂志, 2018,51（4）:247⁃250. doi: 10.3760/cma.j.issn.0412⁃4030.2018.04.001.
［2］	van Geel N, Passeron T, Wolkerstorfer A, et al. Reliability and validity of the Vitiligo Signs of Activity Score （VSAS）［J］. Br J Dermatol, 2020,183（5）:883⁃890. doi: 10.1111/bjd.18950.
［3］	Speeckaert R, Speeckaert M, De Schepper S, et al. Biomarkers of disease activity in vitiligo: a systematic review［J］. Autoimmun Rev, 2017,16（9）:937⁃945. doi: 10.1016/j.autrev.2017.07.005.
［4］	Xiang W, Xu A, Xu J, et al. In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation［J］. Lasers Med Sci, 2010,25（4）:551⁃558. doi: 10.1007/s10103⁃010⁃0764⁃2.
［5］	Bae JM, Oh SH, Kang HY, et al. Development and validation of the Vitiligo Extent Score for a Target Area （VESTA） to assess the treatment response of a target lesion［J］. Pigment Cell Melanoma Res, 2019,32（2）:315⁃319. doi: 10.1111/pcmr.12730.
［6］	Hamzavi I, Jain H, McLean D, et al. Parametric modeling of narrowband UV⁃B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index［J］. Arch Dermatol, 2004,140（6）:677⁃683. doi: 10.1001/archderm.140.6. 677.
［7］	van Geel N, Lommerts J, Bekkenk M, et al. Development and validation of the Vitiligo Extent Score （VES）: an international collaborative initiative［J］. J Invest Dermatol, 2016,136（5）:978⁃984. doi: 10.1016/j.jid.2015.12.040.
［8］	Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference［J］. Pigment Cell Melanoma Res, 2012,25（3）:E1⁃E13. doi: 10.1111/j.1755⁃148X.2012.00997.x.
［9］	Rodrigues M, Ezzedine K, Hamzavi I, et al. Current and emerging treatments for vitiligo［J］. J Am Acad Dermatol, 2017,77（1）:17⁃29. doi: 10.1016/j.jaad.2016.11.010.
［10］	Kanwar AJ, Mahajan R, Parsad D. Low⁃dose oral mini⁃pulse dexamethasone therapy in progressive unstable vitiligo［J］. J Cutan Med Surg, 2013,17（4）:259⁃268. doi: 10.2310/7750.2013. 12053.
［11］	Lee J, Chu H, Lee H, et al. A retrospective study of methylprednisolone mini⁃pulse therapy combined with narrow⁃band UVB in non⁃segmental vitiligo［J］. Dermatology, 2016,232（2）:224⁃229. doi: 10.1159/000439563.
［12］	林洁, 樊奇敏, 许爱娥. 窄谱中波紫外线治疗白癜风平台期相关研究［J］. 临床皮肤科杂志, 2016,45（6）:465⁃468.
［13］	Khullar G, Kanwar AJ, Singh S, et al. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB⁃UVB vs. NB⁃UVB alone in the treatment of vitiligo: a 24⁃week prospective right⁃left comparative clinical trial［J］. J Eur Acad Dermatol Venereol, 2015,29（5）:925⁃932. doi: 10.1111/jdv.12726.
［14］	Hu W, Xu Y, Ma Y, et al. Efficacy of the topical calcineurin inhibitors tacrolimus and pimecrolimus in the treatment of vitiligo in infants under 2 years of age: a randomized, open⁃label pilot study［J］. Clin Drug Investig, 2019,39（12）:1233⁃1238. doi: 10.1007/s40261⁃019⁃00845⁃x.
［15］	Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo［J］. Br J Dermatol, 2001,145（3）:476⁃479. doi: 10.1046/j.1365⁃2133.2001.04381.x.
［16］	de Menezes AF, Oliveira de Carvalho F, Barreto RS, et al. Pharmacologic treatment of vitiligo in children and adolescents: a systematic review［J］. Pediatr Dermatol, 2017,34（1）:13⁃24. doi: 10.1111/pde.13024.
［17］	Margolis DJ, Abuabara K, Hoffstad OJ, et al. Association between malignancy and topical use of pimecrolimus［J］. JAMA Dermatol, 2015,151（6）:594⁃599. doi: 10.1001/jamadermatol. 2014.4305.
［18］	Oiso N, Kawada A. Freckling promoted by topical tacalcitol in a Japanese boy with left eyelid vitiligo［J］. Pediatr Dermatol, 2012,29（5）:671⁃672. doi: 10.1111/j.1525⁃1470.2011.01559.x.
［19］	Passeron T. Medical and maintenance treatments for vitiligo［J］. Dermatol Clin, 2017,35（2）:163⁃170. doi: 10.1016/j.det.2016. 11.007.
［20］	Mohammad TF, Al⁃Jamal M, Hamzavi IH, et al. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo［J］. J Am Acad Dermatol, 2017,76（5）:879⁃888. doi: 10.1016/j.jaad.2016.12.041.
［21］	Rosmarin D , Pandya A G , Lebwohl M , et al. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial［J］. The Lancet, 2020,396（10244）:110⁃120. doi:10.1016/S0140⁃6736（20）30609⁃7.

[1]	Zhang Ning, Li Shu, Li Jing . Efficacy of immune checkpoint inhibitors and targeted therapy in adjuvant treatment of resectable melanoma: a network meta-analysis [J]. Chinese Journal of Dermatology, 2022, 0(4): 20200767-e20200767.
[2]	Li Yan, Li Ming, Xu Wei, Li Linfeng. Efficacy of fluticasone propionate cream alone or in combination with calcipotriol ointment in the treatment of mild to moderate plaque psoriasis: a randomized self-controlled study [J]. Chinese Journal of Dermatology, 2022, 55(3): 260-263.
[3]	Fu Chao, Wu Jiaona, Lang Wenchao, Gao Fei, Niu Guiye, Bian Peiwen, Gao Minhong, Si Xiaoqing, Xin Linlin. Role of dermoscopy in assessing vitiligo activity [J]. Chinese Journal of Dermatology, 2022, 55(3): 268-271.
[4]	Liu Yuzhen, Zeng Rong, Zheng Nana, Duan Zhimin, Xu Haoxiang, Wu Qiuju, Lin Tong, Li Min. Effect of different incubation time of aminolevulinic acid on photodynamic inhibition of Propionibacterium acnes biofilms [J]. Chinese Journal of Dermatology, 2022, 55(3): 208-212.
[5]	Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement （2022） [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195.
[6]	Ainiwaer·Talifu, Xiong Cheng, Refuhati·Saimaiti, Yusufu·Maitinuer, Tuerxun·Wufuer, Akenmujiang·Aierken, Julaiti·Abuduwayiti, Maimaitiaili·Kade. Identification and analysis of differentially expressed genes in vitiligo using bioinformatics methods [J]. Chinese Journal of Dermatology, 2022, 0(2): 20200391-e20200391.
[7]	Wen Guangdong, Mao Dandan, Zhang Yuanyuan, Dou Yuanqing, Zhao Pei, Wu Chenyu, Zhang Jianzhong. A case of generalized lichen amyloidosis treated with dupilumab: the first case reported in China [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210694-e20210694.
[8]	Li Sai, Xue Huazhong, Zhang Shuwen, Jiang Juan, Qi Shuzhen, Zhao Yuanyuan, Zhang Jinping, Sha Zhong, Le Wenjing, Wang Biwei, Zhao Shixuan, Zhu Xiaofeng, Su Xiaohong. Doxycycline-moxifloxacin sequential therapy for Mycoplasma genitalium urethritis/cervicitis: a clinical observation [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210631-e20210631.
[9]	Jiao Xiaoyan, Yin Guangwen, Yin Yakun, Li Dongqin. Clinical analysis of 25 cases of herpes zoster during pregnancy or the perinatal period [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210384-e20210384.
[10]	Ou Min, Yan Yunling, Zheng Baoqing, Wang Xiaohua. Correlations between psoriasis and obesity [J]. Chinese Journal of Dermatology, 2022, 55(2): 181-184.
[11]	Bao Shijie, Cheng Yang, Yan Ying, Fan Fang, Gao Tingting, Feng Xiaolan, Zheng Liang, Lei Wei, Huang Qinsi, Zhang Weiming, Zhou Xiaoyong. A comparative study of human immunoglobulin versus recombinant human tumor necrosis factor-α receptor Ⅱ:IgG Fc fusion protein in the treatment of toxic epidermal necrolysis [J]. Chinese Journal of Dermatology, 2022, 55(2): 153-156.
[12]	Guo Jing, Yang Jingyu, Ding Li, Liu Mingming, Hou Jingmei, Pu Xiaoxia, Sun Jiayu, Li Xianghua. Efficacy of long-pulsed 1 064-nm Nd:YAG laser combined with a topical emulsion containing Camellia reticulata and Radix Notoginseng in the treatment of melasma [J]. Chinese Journal of Dermatology, 2022, 55(1): 61-64.
[13]	Chinese Society of Dermatology, China Dermatologist Association. Consensus on the diagnosis and treatment of autoimmune subepidermal bullous diseases （2022） [J]. Chinese Journal of Dermatology, 2022, 55(1): 1-11.
[14]	Chen Yi, Song Xiuzu. Role of transient receptor potential channels in melanocytes and their related diseases [J]. Chinese Journal of Dermatology, 2022, 0(1): 20200958-e20200958.
[15]	Luan Chao, Hu Yu, Chen Kun, Zhang Jiaan, Gu Heng, Zhang Ronglin, Zhang Xiaohua, Tian Panpan, Zhu Yan, Zhuang Chen, Huang Dan, Ju Mei. Efficacy and safety of 308-nm SQ light-emitting diode light and 308-nm excimer light in the treatment of facial vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2022, 55(1): 16-19.

Consensus on the diagnosis and treatment of vitiligo （2021 version）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［21］

Related Articles 15

Metrics

Comments

Recommended 10